Vital Therapies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VTL and buy or sell other stocks, ETFs, and their options commission-free!About VTL
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt, PhD
CEODaniel Vitt, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees—
Employees—
VTL Key Statistics
Market cap79.54M
Market cap79.54M
Price-Earnings ratio-0.85
Price-Earnings ratio-0.85
Dividend yield—
Dividend yield—
Average volume934.60K
Average volume934.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.11
52 Week high$2.11
52 Week low$0.561
52 Week low$0.561